Disposable manufacturing tech

GettyImages/Gam1983

BIOPRODUCTION CONGRESS DUBLIN 2017

Integrating disposable tech? Size matters, says BMS

By Flora Southey

Size can be a restricting factor when introducing single-use technologies into a pre-existing facility according to BMS, which hopes to integrate disposable equipment at a US-based site.

Repligen talks product diversification through M&A and R&D

Exclusive interview from Biotech Week Boston

Balancing the up and downstream: Repligen CEO talks R&D and M&A

By Dan Stanton

Repligen’s customer GE Healthcare opted to make its latest Protein A ligand in-house, but CEO Tony Hunt remains confident in his firm’s long-term partnerships and diversified bioprocessing offering.